4//SEC Filing
Quinn William P. 4
Accession 0001193125-25-321146
CIK 0001641281other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 5:11 PM ET
Size
38.3 KB
Accession
0001193125-25-321146
Insider Transaction Report
Form 4
Quinn William P.
DirectorPresident, CEO and CFO
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-12-12+7,614→ 7,614 totalExercise: $5.44Exp: 2030-07-28→ Common Stock (7,614 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−7,614→ 0 totalExercise: $56.00Exp: 2030-07-28→ Common Stock (7,614 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+3,927→ 3,927 totalExercise: $5.44Exp: 2030-09-02→ Common Stock (3,927 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−3,927→ 0 totalExercise: $86.80Exp: 2030-09-02→ Common Stock (3,927 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+5,000→ 5,000 totalExercise: $5.44Exp: 2031-02-03→ Common Stock (5,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−5,000→ 0 totalExercise: $400.00Exp: 2031-02-03→ Common Stock (5,000 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+10,499→ 10,499 totalExercise: $5.44Exp: 2032-02-17→ Common Stock (10,499 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−10,499→ 0 totalExercise: $61.60Exp: 2032-02-17→ Common Stock (10,499 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+12,499→ 12,499 totalExercise: $5.44Exp: 2033-02-26→ Common Stock (12,499 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−12,499→ 0 totalExercise: $31.80Exp: 2033-02-26→ Common Stock (12,499 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+11,749→ 11,749 totalExercise: $5.44Exp: 2034-03-03→ Common Stock (11,749 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−11,749→ 0 totalExercise: $25.40Exp: 2034-03-03→ Common Stock (11,749 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+21,999→ 21,999 totalExercise: $5.44Exp: 2034-07-22→ Common Stock (21,999 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−21,999→ 0 totalExercise: $14.60Exp: 2034-07-22→ Common Stock (21,999 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+34,999→ 34,999 totalExercise: $5.44Exp: 2035-04-30→ Common Stock (34,999 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−34,999→ 0 totalExercise: $7.02Exp: 2035-04-30→ Common Stock (34,999 underlying)
Footnotes (13)
- [F1]The option is fully vested and exercisable.
- [F10]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024.
- [F11]The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price.
- [F12]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025.
- [F13]The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price.
- [F2]The reporting person agreed to cancellation of an option granted on July 29, 2020, in exchange for a new option having a lower price.
- [F3]The reporting person agreed to cancellation of an option granted on September 3, 2020, in exchange for a new option having a lower exercise price.
- [F4]The reporting person agreed to cancellation of an option granted on February 4, 2021, in exchange for a new option having a lower exercise price.
- [F5]The reporting person agreed to cancellation of an option granted on February 18, 2022, in exchange for a new option having a lower exercise price.
- [F6]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2023.
- [F7]The reporting person agreed to cancellation of an option granted on February 27, 2023, in exchange for a new option having a lower exercise price.
- [F8]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024.
- [F9]The reporting person agreed to cancellation of an option granted on March 4, 2024, in exchange for a new option having a lower exercise price.
Documents
Issuer
Bolt Biotherapeutics, Inc.
CIK 0001641281
Entity typeother
Related Parties
1- filerCIK 0001724190
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 5:11 PM ET
- Size
- 38.3 KB